|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Fair Value | |||||||||||||||||
| Non-controlled/non-affiliate company investments | |||||||||||||||||
| Non-controlled affiliate company investments | |||||||||||||||||
| Controlled affiliate company investments | |||||||||||||||||
| Total fair Value | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Restricted cash | |||||||||||||||||
| Interest receivable | |||||||||||||||||
| Receivable for open trades | |||||||||||||||||
| Derivative assets | |||||||||||||||||
| Interest rate swap | |||||||||||||||||
| Total derivative assets | |||||||||||||||||
| Other assets | |||||||||||||||||
| Operating lease right-of-use asset | |||||||||||||||||
| Total assets | |||||||||||||||||
| LIABILITIES | |||||||||||||||||
| Debt | |||||||||||||||||
| Base management fee payable | |||||||||||||||||
| Income based fee payable | |||||||||||||||||
| Capital gains incentive fee payable | |||||||||||||||||
| Interest and facility fees payable | |||||||||||||||||
| Payable to participants | |||||||||||||||||
| Derivative liabilities | |||||||||||||||||
| Interest rate swap | |||||||||||||||||
| Excluding Interest Rate Swap | |||||||||||||||||
| Total derivative liabilities | |||||||||||||||||
| Payable for open trades | |||||||||||||||||
| Accounts payable and other liabilities | |||||||||||||||||
| Deferred tax liabilities | |||||||||||||||||
| Secured borrowings | |||||||||||||||||
| Operating lease liabilities | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| STOCKHOLDERS’ EQUITY | |||||||||||||||||
| Common stock, par value $0.001 per share, 1,000 common shares authorized; 722 and 718 common shares issued and outstanding, respectively | |||||||||||||||||
| Capital in excess of par value | |||||||||||||||||
| Accumulated undistributed earnings | |||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||
| NET ASSET VALUE PER SHARE (in dollars per share) | |||||||||||||||||
| Common stock, shares issued (in shares) | |||||||||||||||||
| Shares outstanding at end of period (in shares) | |||||||||||||||||
Loading...
